Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Sep 26, 2014

Aethlon Medical and Exosome Sciences Announce Clinical Collaboration with Boston University CTE Center To Advance Diagnostic Candidate to Detect CTE in Former NFL Players

Sep 24, 2014

Aethlon Medical Announces Dengue Virus Treatment Agreement

Sep 22, 2014

Aethlon Medical Receives Notice of DARPA Contract Renewal

Sep 17, 2014

Aethlon Medical and Exosome Sciences To Present at the Exosomes & SingleCell Analysis Summit

Sep 10, 2014

Aethlon Medical, Inc. Launches Digital Corporate Communication Channels

Sep 8, 2014

Aethlon Medical and Exosome Sciences Announce the Advancement of a Broad-Spectrum Cancer Detection and Monitoring Platform

Sep 2, 2014

Aethlon Medical Announces Receipt of IRB Approval to Initiate Hemopurifier® Clinical Studies

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.